NCT00115986View on ClinicalTrials.gov

A/H5N1in Adult - Aventis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

452

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

February 28, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza A/H5N1 Vaccine

Trial Locations (3)

21201

University of Maryland Baltimore, Baltimore

90502

UCLA Center For Vaccine Research, Torrance

14642-0001

University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00115986 - A/H5N1in Adult - Aventis | Biotech Hunter | Biotech Hunter